Overview

Details

Support

Resources

Full prescribing information

Overview

Details

Support

Resources

Full prescribing information

Omnipaque™ (lohexol) resources

approved since 1985, this low-osmolar iodinated contrast media is indicated for intravenous, intra-arterial, intrathecal, intraarticular, body cavity and oral use.¹

Oncology

GE HealthCare Quality Tour

Welcome to the GEHC World Class Quality Tour!

video • 3 mins 50 secs

Watch video

Product Webinars / Videos

Quality Handling of Contrast Media

A detailed video concerning the quality handling of Contrast Media

video • 4 mins 5 secs

Watch video

Stay connected with GE HealthCare

Sign up to stay up to date with the latest Omnipaque™ resources

Enter your email address

Email is incorrect

Sign up

Thank you!

We received your request for assistance.

A GE Healthcare specialist will be reaching out shortly.

Something went wrong

We will check and get back.

Try Again

Thank you!

We received your request for assistance.

A GE Healthcare specialist will be reaching out shortly.

Something went wrong

We will check and get back.

Try Again

JB02689IN April 2025